Scholarlink

Objective <p>Describe survival and short-term outcomes of extremely low gestational age neonates (ELGANs) at a tertiary centre in United Arab Emirates (UAE) and to compare outcomes with regional and international data.</p> Study design <p>Prospective single-center cohort study with passive follow up of infants born between 22⁰⁄₇ and 26⁶⁄₇ weeks’ gestation from 2019 to 2025. Survival to discharge and morbidities were evaluated.</p> Results <p>Among 125 ELGANs, survival to discharge increased from 31% at 22 weeks to 88% at 26 weeks gestational age. Survival among peri-viable infants was higher than regional cohorts and comparable to high-income countries. Major morbidities among survivors included bronchopulmonary dysplasia (54%), intraventricular hemorrhage (53%), and retinopathy of prematurity requiring treatment (36%).</p> Conclusion <p>ELGAN survival in this UAE center was comparable to international benchmarks, though morbidity remains substantial. Improved peri-viable survival compared with regional data may reflect impact of active perinatal care and supports its role in improving outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Survival and pre-discharge outcomes of extremely preterm neonates: a single- center prospective cohort study from the United Arab Emirates

  • 期刊论文

  • 发表日期：

    2026年7月20日

查看全文
  • Sangeeta Santosh Kumar,
  • Venkateshwarlu Vardhelli,
  • Nicholas Hoque,
  • Mohammed Khalil,
  • Dumisani Kamwana,
  • Zakariya Bambala Puthattayil,
  • Fares Chedid

摘要

Objective

Describe survival and short-term outcomes of extremely low gestational age neonates (ELGANs) at a tertiary centre in United Arab Emirates (UAE) and to compare outcomes with regional and international data.

Study design

Prospective single-center cohort study with passive follow up of infants born between 22⁰⁄₇ and 26⁶⁄₇ weeks’ gestation from 2019 to 2025. Survival to discharge and morbidities were evaluated.

Results

Among 125 ELGANs, survival to discharge increased from 31% at 22 weeks to 88% at 26 weeks gestational age. Survival among peri-viable infants was higher than regional cohorts and comparable to high-income countries. Major morbidities among survivors included bronchopulmonary dysplasia (54%), intraventricular hemorrhage (53%), and retinopathy of prematurity requiring treatment (36%).

Conclusion

ELGAN survival in this UAE center was comparable to international benchmarks, though morbidity remains substantial. Improved peri-viable survival compared with regional data may reflect impact of active perinatal care and supports its role in improving outcomes.